CONMED EPS - Earnings per Share 2010-2024 | CNMD
CONMED eps - earnings per share from 2010 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| CONMED Annual EPS |
| 2023 |
$2.04 |
| 2022 |
$-2.68 |
| 2021 |
$1.94 |
| 2020 |
$0.32 |
| 2019 |
$0.97 |
| 2018 |
$1.41 |
| 2017 |
$1.97 |
| 2016 |
$0.52 |
| 2015 |
$1.09 |
| 2014 |
$1.16 |
| 2013 |
$1.28 |
| 2012 |
$1.41 |
| 2011 |
$0.03 |
| 2010 |
$1.05 |
| 2009 |
$0.42 |
| CONMED Quarterly EPS |
| 2024-03-31 |
$0.63 |
| 2023-12-31 |
$1.05 |
| 2023-09-30 |
$0.50 |
| 2023-06-30 |
$0.43 |
| 2023-03-31 |
$0.06 |
| 2022-12-31 |
$1.02 |
| 2022-09-30 |
$1.48 |
| 2022-06-30 |
$-5.65 |
| 2022-03-31 |
$0.47 |
| 2021-12-31 |
$0.75 |
| 2021-09-30 |
$0.47 |
| 2021-06-30 |
$0.41 |
| 2021-03-31 |
$0.31 |
| 2020-12-31 |
$0.85 |
| 2020-09-30 |
$0.23 |
| 2020-06-30 |
$-0.96 |
| 2020-03-31 |
$0.20 |
| 2019-12-31 |
$0.51 |
| 2019-09-30 |
$0.23 |
| 2019-06-30 |
$0.19 |
| 2019-03-31 |
$0.04 |
| 2018-12-31 |
$0.54 |
| 2018-09-30 |
$0.20 |
| 2018-06-30 |
$0.30 |
| 2018-03-31 |
$0.37 |
| 2017-12-31 |
$1.65 |
| 2017-09-30 |
$0.26 |
| 2017-06-30 |
$0.22 |
| 2017-03-31 |
$-0.16 |
| 2016-12-31 |
$0.24 |
| 2016-09-30 |
$0.26 |
| 2016-06-30 |
$0.10 |
| 2016-03-31 |
$-0.08 |
| 2015-12-31 |
$0.27 |
| 2015-09-30 |
$0.32 |
| 2015-06-30 |
$0.27 |
| 2015-03-31 |
$0.23 |
| 2014-12-31 |
$0.41 |
| 2014-09-30 |
$0.07 |
| 2014-06-30 |
$0.37 |
| 2014-03-31 |
$0.31 |
| 2013-12-31 |
$0.37 |
| 2013-09-30 |
$0.20 |
| 2013-06-30 |
$0.34 |
| 2013-03-31 |
$0.37 |
| 2012-12-31 |
$0.38 |
| 2012-09-30 |
$0.32 |
| 2012-06-30 |
$0.36 |
| 2012-03-31 |
$0.35 |
| 2011-12-31 |
$-0.87 |
| 2011-09-30 |
$0.29 |
| 2011-06-30 |
$0.30 |
| 2011-03-31 |
$0.31 |
| 2010-12-31 |
$0.24 |
| 2010-09-30 |
$0.31 |
| 2010-06-30 |
$0.25 |
| 2010-03-31 |
$0.25 |
| 2009-12-31 |
$0.18 |
| 2009-09-30 |
$0.04 |
| 2009-06-30 |
$0.05 |
| 2009-03-31 |
$0.15 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$1.906B |
$1.245B |
|
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
|
